04 October 2019

Sale of NVT AG to Blue Sail Medical

King & Wood Mallesons (KWM) has advised the shareholders of NVT AG (NVT) on the sale to Blue Sail Medical Co., Ltd. (Blue Sail Medical).
NVT is a privately owned Swiss company with production sites in Germany. NVT develops, manufactures and markets medical devices for interventional cardiology and cardiac surgery for minimally invasive treatment of valvular heart disease. Blue Sail Medical, a Chinese medical device company, is listed at Shenzhen Stock Exchange. 

The share purchase agreement to acquire NVT has been signed – the closing of the transaction is subject to customary closing conditions.  

The Frankfurt KWM team around partner Dr. Sandra Link acted as German and Chinese counsel to the sellers and advised the NVT together with colleagues from Beijing on German and Chinese law issues. The Swiss law firm Walder Wyss accompanied the transaction as lead counsel and global coordinator.  

Advisors NVT AG:

KWM Frankfurt: Dr. Sandra Link (partner), Dr. Tilmann Becker (counsel | AWG key contact) (both Corporate/M&A), Markus Hill (partner), Viktoria Rosbach (associate) (both Tax) 

KWM Beijing: PAN Zhenhua (partner), ZHANG Dai (associate) (both Corporate/M&A)

Media Contact

Share on LinkedIn Share on Facebook Share on Twitter
    You might also be interested in

    KWM has advised Silver Investment Partners on the acquisition of a majority stake in Lucien Ortscheit GmbH.

    15 May 2020

    KWM gains Dr. Peter Polke as Counsel thus strengthening its M&A and private equity practice and continuing the successful growth of the past 3 years.

    24 March 2020

    KWM has advised Ninestar Corporation on the investment in the German tonerdumping.de Orth & Baer GmbH

    02 March 2020

    KWM has advised ISVision (Huangzhou) Technology Co, Ltd. on the acquisition of EHR GmbH & Co. KG, a specialist of high-precision measurement.

    07 February 2020

    You may also be interested in...

    This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

    For more information on which cookies we use then please refer to our Cookie Policy.